Careers Media center Contacts

ORNIZOL




Active substance: ornidazole

ATC: J01X D03

How supplied: Solution for injection

Dosage form
Solution for injection 100 ml №1.

Active ingredient
1 ml of solution contains ornidazole 5 mg.

Indications
Parenteral administration of the medication is indicated in cases of acute and severe infection or where oral administration is impossible for the following diseases and conditions: anaerobic systemic infections caused by microflora susceptible to ornidazole: septicemia, meningitis, peritonitis, postoperative wound infections, puerperal sepsis, septic abortion and endometritis; prevention of infections caused by anaerobic bacteria in surgical interventions (especially during surgeries on the colon and rectum), gynaecological surgeries; severe course of amoebic dysentery, all extra-intestinal forms of amoebiasis, giardiasis, liver abscess.

ATTENTION!

The following information is intended for medical and pharmaceutical professionals only and can be used exclusively in professional activities.

ARE YOU A MEDICAL AND/OR PHARMACEUTICAL PROFESSIONAL?

(submitting the answer, you bear full responsibility for the accuracy of the information provided)


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form